PH Deck logoPH Deck

Fill arrow
Production Automatic Peptide Synthesizer
Brown line arrowSee more Products
Production Automatic Peptide Synthesizer
Synthesizer
# Synthesis
Featured on : Feb 11. 2025
Featured on : Feb 11. 2025
What is Production Automatic Peptide Synthesizer?
The PSI586 production model fully automated peptide synthesiser production model is green with solvent recirculation system(SRS).
Problem
Scientists and researchers currently use traditional peptide synthesis methods which often involve manual operations and external interventions.
Manual operations and external interventions lead to inefficiencies, increased labor costs, potential errors, and environmental concerns due to solvent waste.
Solution
A fully automated peptide synthesizer production model with a solvent recirculation system.
Users can automate the synthesis of peptides, reducing manual labor and solvent waste. For example, researchers can program the system for continuous production without manual interference.
automated peptide synthesizer production model and solvent recirculation system
Customers
Researchers and scientists in biochemistry and pharmaceutical sectors
They are looking to improve efficiency, accuracy, and sustainability in peptide synthesis
Unique Features
Fully automated system that reduces the need for manual intervention.
Incorporates a solvent recirculation system to minimize waste and environmental impact.
User Comments
Users appreciate the automation and reduction in manual labor.
The inclusion of solvent recirculation is praised for environmental benefits.
Optimizes synthesis time and increases throughput.
Some users might find the initial setup cost high.
User feedback highlights increased accuracy and consistency in peptide production.
Traction
Launched recently as indicated on ProductHunt.
Specific user or revenue data not available.
Market interest appears focused on sustainability and automation in chemical processes.
Market Size
The global peptide synthesis market is projected to reach $426.5 million by 2027, driven by increasing research activities and demand for custom peptide synthesis.